Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.
Salzmann RJS, Krötz C, Mocan T, Mocan LP, Grapa C, Rottmann S, Reichelt R, Keller CM, Langhans B, Schünemann F, Pohl A, Böhler T, Bersiner K, Krawczyk M, Milkiewicz P, Sparchez Z, Lammert F, Gehlert S, Gonzalez-Carmona MA, Willms A, Strassburg CP, Kornek MT, Dold L, Lukacs-Kornek V. Salzmann RJS, et al. Among authors: mocan lp. Hepatol Commun. 2024 Feb 14;8(3):e0380. doi: 10.1097/HC9.0000000000000380. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358371 Free PMC article.
Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer.
Piekuś-Słomka N, Mocan LP, Shkreli R, Grapă C, Denkiewicz K, Wesolowska O, Kornek M, Spârchez Z, Słomka A, Crăciun R, Mocan T. Piekuś-Słomka N, et al. Among authors: mocan lp. Cancers (Basel). 2023 Oct 22;15(20):5100. doi: 10.3390/cancers15205100. Cancers (Basel). 2023. PMID: 37894467 Free PMC article. Review.
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.
Mocan LP, Craciun R, Grapa C, Melincovici CS, Rusu I, Al Hajjar N, Sparchez Z, Leucuta D, Ilies M, Sparchez M, Mocan T, Mihu CM. Mocan LP, et al. Cancer Immunol Immunother. 2023 Apr;72(4):1003-1014. doi: 10.1007/s00262-022-03309-y. Epub 2022 Oct 17. Cancer Immunol Immunother. 2023. PMID: 36251029 Free PMC article.
Novel approaches in search for biomarkers of cholangiocarcinoma.
Mocan LP, Ilieș M, Melincovici CS, Spârchez M, Crăciun R, Nenu I, Horhat A, Tefas C, Spârchez Z, Iuga CA, Mocan T, Mihu CM. Mocan LP, et al. World J Gastroenterol. 2022 Apr 21;28(15):1508-1525. doi: 10.3748/wjg.v28.i15.1508. World J Gastroenterol. 2022. PMID: 35582128 Free PMC article. Review.
Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma.
Mocan T, Ilies M, Nenu I, Craciun R, Horhat A, Susa R, Minciuna I, Rusu I, Mocan LP, Seicean A, Iuga CA, Hajjar NA, Sparchez M, Leucuta DC, Sparchez Z. Mocan T, et al. Among authors: mocan lp. Int Immunopharmacol. 2021 May;94:107467. doi: 10.1016/j.intimp.2021.107467. Epub 2021 Feb 18. Int Immunopharmacol. 2021. PMID: 33611059
12 results